Advanced search
Publication Cover
Clinical Toxicology Volume 44, 2006 - Issue 4
Submit an article Journal homepage
5,963
Views
3
CrossRef citations to date
0
Altmetric
Abstracts

Abstracts of the European Association of Poisons Centres and Clinical Toxicologists XXVI International Congress

Pages 401-586 | Published online: 07 Oct 2008

Figures & data

TABLE 1

TABLE 1

TABLE 1 Examples of drugs causing repolarisation delay

TABLE 1

TABLE 2

TABLE 1 Number of downloads and accesses to individual pages of the EAPCCT website

FIG. 1 Model of a comprehensive category system for substances in PCs

FIG. 1 Model of a comprehensive category system for substances in PCs

TABLE 1 Comparison of poison center international exposure contact rates using population and URDDs denominators

TABLE 1 Areas of diversification in poisons centres for different reasons

FIG. 1 Enquiry numbers and income of the VPIS (at 26.10.05)

FIG. 1 Enquiry numbers and income of the VPIS (at 26.10.05)

TABLE 1 Measures of cognitive processing in test and control groups

FIG. 1 Mean plasma concentrations over time for GHB and BD after oral administration of 25 mg/kg BD

FIG. 1 Mean plasma concentrations over time for GHB and BD after oral administration of 25 mg/kg BD

TABLE 1 The number of workers exposed to selected chemicals in the year 2005

TABLE 2 Acute and chronic occupational intoxications with chemicals; most common causes and total number of intoxications

TABLE 3 The number of all hospitalisations due to intoxications with chemicals

TABLE 1 Common causes of acute, drug-induced confusion

TABLE 2 Drugs useful in the management of drug-induced confusion

TABLE 1 Outcome after frequent ethylene glycol (EG) poisonings

TABLE 1 Results

FIG. 1

FIG. 1

TABLE 1 Laboratory values

TABLE 1

FIG. 1

FIG. 1

FIG. 1

FIG. 1

FIG. 1

FIG. 1

FIG. 1

FIG. 1

FIG. 1

FIG. 1

TABLE 1 Patient characteristics

TABLE 1

TABLE 1

FIG. 1

FIG. 1

TABLE 1 Causes, syndromes and complications of our patients treated because of rhabdomyolysis

TABLE 1 Urgent conditions in poisonings by different toxic agents

TABLE 1

TABLE 1 Frequency of drugs found in urine of methadone poisoned patients

TABLE 1 Call numbers received by New Zealand National Poisons Centre: 1995–2005

FIG. 1 North of England ADQ usage

FIG. 1 North of England ADQ usage

FIG. 1 Hospital admissions and poisons centre enquiries

FIG. 1 Hospital admissions and poisons centre enquiries

TABLE 1 Overview of EG poisonings in the European states

TABLE 1

TABLE 1

TABLE 1 Organophosphate exposures in the United States (TESS Data, 1995–2004)

TABLE 1 Tricyclic antidepressant poisoning in Wales 1999–2003

TABLE 1

TABLE 1 Number of calls to TIC and hospitalizations due to corrosives in the years 2000 – 2004

TABLE 1 Total number of deaths (mortality) and discharges from hospitals (morbidity) due to acute poisonings in the Nordic countries in 2002 per 100000 inhabitants

TABLE 1 Percentages of calls involving dextroproxyphene

TABLE 1

FIG. 1 Quantitative evaluation of CD68 immunopositivity

FIG. 1 Quantitative evaluation of CD68 immunopositivity

TABLE 1 24 h-Urine analysis after Puromycin and Taurine administration in rats

TABLE 2 Semiquantitative analysis of interstitial collagen

TABLE 1 Availability of IA in different hospital level

FIG. 1

FIG. 1

TABLE 1 Availability of IA in different hospital level (NA = not applicable)

FIG. 1 Evolution of methaemoglobin and lactate levels

FIG. 1 Evolution of methaemoglobin and lactate levels

TABLE 1

TABLE 1 Cesium cases

FIG. 1 Respiratory cases after exposure to a textile proofing agent in 2005

FIG. 1 Respiratory cases after exposure to a textile proofing agent in 2005

FIG. 1

FIG. 1

TABLE 1 pH measurements

FIG. 1 GHB concentrations in serial times urine collections in 16 humans administered 50 mg/kg GHB alone (solid diamonds), and with 0.6 mg/kg ethanol (open triangles). Horizontal lines represent mean values

FIG. 1 GHB concentrations in serial times urine collections in 16 humans administered 50 mg/kg GHB alone (solid diamonds), and with 0.6 mg/kg ethanol (open triangles). Horizontal lines represent mean values

FIG. 1

FIG. 1

TABLE 1 Patient characteristics

TABLE 1 Outcome of pregnancy following maternal monotherapy with antipsychotic drugs

TABLE 1 Outcome of pregnancy following maternal treatment with triazoles

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.